ºÚÁÏÍø

Skip to main content

Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor

January 27, 2022
Dr. Timothy Gershon is co-corresponding author of new research that appeared in Sciences Advances, January 26, 2022.

Neurology News – January 2022

January 11, 2022
What’s new in the Department of Neurology

FDA approves new drug to treat generalized myasthenia gravis

January 3, 2022
James F. Howard Jr., MD, professor in the ºÚÁÏÍø Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

Diaz Receives AAN Clinical Research Training Scholarship

December 13, 2021
The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.

James Ho receives Junior Faculty Development Award

November 30, 2021
James Pham Ho, MD, receives $10,000 Junior Faculty Development Award

Duke-ºÚÁÏÍø ADRC announces three research funding opportunities

November 10, 2021
The Duke/ºÚÁÏÍø ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and ºÚÁÏÍø studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from ºÚÁÏÍø Pembroke, North Carolina Central University, and East Carolina University.

Neurology News – November 2021

November 1, 2021
What’s new in the Department of Neurology

ºÚÁÏÍø Neurology Receives New Center of Excellence Designation

September 1, 2021
The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.

Neurology News – September 2021

August 31, 2021
What’s new in the Department of Neurology